Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology

Integration of human papillomavirus (HPV) DNA into the host genome can be a driver mutation in cervical carcinoma. Identification of HPV integration at base resolution has been a longstanding technical challenge, largely due to sensitivity masking by HPV in episomes or concatenated forms. The aim was to enhance the understanding of the precise localization of HPV integration sites using an innovative strategy. Using HPV capture technology combined with next generation sequencing, HPV prevalence and the exact integration sites of the HPV DNA in 47 primary cervical cancer samples and 2 cell lines were investigated. A total of 117 unique HPV integration sites were identified, including HPV16 (n = 101), HPV18 (n = 7), and HPV58 (n = 9). We observed that the HPV16 integration sites were broadly located across the whole viral genome. In addition, either single or multiple integration events could occur frequently for HPV16, ranging from 1 to 19 per sample. The viral integration sites were distributed across almost all the chromosomes, except chromosome 22. All the cervical cancer cases harboring more than four HPV16 integration sites showed clinical diagnosis of stage III carcinoma. A significant enrichment of overlapping nucleotides shared between the human genome and HPV genome at integration breakpoints was observed, indicating that it may play an important role in the HPV integration process. The results expand on knowledge from previous findings on HPV16 and HPV18 integration sites and allow a better understanding of the molecular basis of the pathogenesis of cervical carcinoma.

[1]  Shih-hung Huang,et al.  Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. , 2006, Gynecologic oncology.

[2]  H. Ito,et al.  Mutation and transcription analyses of the p63 gene in cervical carcinoma. , 1999, International journal of oncology.

[3]  N. Bannert,et al.  Retroelements and the human genome: New perspectives on an old relation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Thorland,et al.  Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. , 2000, Cancer research.

[5]  M Arbyn,et al.  Worldwide burden of cervical cancer in 2008. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  F. Vasilescu,et al.  P53, p63 and Ki-67 assessment in HPV-induced cervical neoplasia. , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[7]  M. Wagatsuma,et al.  Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences , 1990, Journal of virology.

[8]  X. Castellsagué.  Natural history and epidemiology of HPV infection and cervical cancer. , 2008, Gynecologic oncology.

[9]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[10]  R. Schlegel,et al.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. , 1985, The American journal of pathology.

[11]  M. Mravunac,et al.  Transition of high‐grade cervical intraepithelial neoplasia to micro‐invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities , 2004, The Journal of pathology.

[12]  S. Corden,et al.  The integration of HPV-18 DNA in cervical carcinoma. , 1999, Molecular pathology : MP.

[13]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[14]  M. Campion,et al.  Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm , 1991, Journal of virology.

[15]  S. Vinokurova,et al.  Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions , 2002, Oncogene.

[16]  Nicolas Stransky,et al.  Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma , 2010, The Journal of pathology.

[17]  A. Venuti,et al.  HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness , 2002, Journal of medical virology.

[18]  A. Fiander,et al.  HPV integration detection in CaSki and SiHa using detection of integrated papillomavirus sequences and restriction-site PCR. , 2014, Journal of virological methods.

[19]  S. Franceschi,et al.  Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication , 2011, International journal of cancer.

[20]  M. Hoeckel,et al.  A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques , 2003, Oncogene.

[21]  S. O’Brien,et al.  Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. , 1987, Virology.

[22]  Magnus von Knebel Doeberitz,et al.  Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. , 2008, Cancer research.

[23]  N. Coleman,et al.  Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis? , 2007, The Journal of pathology.

[24]  Paul Theodor Pyl,et al.  The Genomic and Transcriptomic Landscape of a HeLa Cell Line , 2013, G3: Genes, Genomes, Genetics.

[25]  A. Mincheva,et al.  Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization , 1987, Medical Microbiology and Immunology.

[26]  N. Muñoz,et al.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. , 2010, The Lancet. Oncology.

[27]  G. Fleuren,et al.  Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. , 1999, Cancer research.

[28]  M. von Knebel Doeberitz,et al.  Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells , 2001, International journal of cancer.

[29]  David I. Smith,et al.  Common fragile sites are preferential targets for HPV16 integrations in cervical tumors , 2003, Oncogene.

[30]  Cary A Moody,et al.  Human papillomavirus oncoproteins: pathways to transformation , 2010, Nature Reviews Cancer.

[31]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[32]  M. von Knebel Doeberitz,et al.  Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. , 1999, Cancer research.

[33]  S. Wolf,et al.  Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas , 2013, PloS one.

[34]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[35]  S. Vinokurova,et al.  Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract , 2004, Cancer Research.

[36]  M. Braun,et al.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines , 1987, Journal of virology.